Cited by 219Alzheimer's disease research and treatmentsNeuroinflammation and Neurodegeneration MechanismsDementia and Cognitive Impairment Research

The DOI matches its Crossref record; 81 of the 81 references it cites were found in a registry or an index.

Diverse human astrocyte and microglial transcriptional responses to Alzheimer’s pathology

Open access

Published version of a preprint

Abstract

To better define roles that astrocytes and microglia play in Alzheimer’s disease (AD), we used single-nuclei RNA-sequencing to comprehensively characterise transcriptomes in astrocyte and microglia nuclei selectively enriched during isolation post-mortem from neuropathologically defined AD and control brains with a range of amyloid-beta and phospho-tau (pTau) pathology. Significant differences in glial gene expression (including AD risk genes expressed in both the astrocytes [ CLU , MEF2C , IQCK ] and microglia [ APOE , MS4A6A , PILRA ]) were correlated with tissue amyloid or pTau expression. The differentially expressed genes were distinct between with the two cell types and pathologies, although common (but cell-type specific) gene sets were enriched with both pathologies in each cell type. Astrocytes showed enrichment for proteostatic, inflammatory and metal ion homeostasis pathways. Pathways for phagocytosis, inflammation and proteostasis were enriched in microglia and perivascular macrophages with greater tissue amyloid, but IL1-related pathway enrichment was found specifically in association with pTau. We also found distinguishable sub-clusters in the astrocytes and microglia characterised by transcriptional signatures related to either homeostatic functions or disease pathology. Gene co-expression analyses revealed potential functional associations of soluble biomarkers of AD in astrocytes ( CLU ) and microglia ( GPNMB ). Our work highlights responses of both astrocytes and microglia for pathological protein clearance and inflammation, as well as glial transcriptional diversity in AD.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s00401-021-02372-6

Cites

81 of 81 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Analysis of human brain microglia and astrocytes from low and high AD pathology brains by single-nuclei RNASeq. a FACS gating method for sorting of human brain nuclei to enrich for microglia and astrocyte double-negative population (pink; mean for 24 samples = 17.9%, standard deviation = 6.2%). Dapi + ve nuclei were selected first, followed by separation based on NeuN and Sox10 staining. b UMAP 2D visualisation of clustering of 91,655 single nuclei from the 24 brain samples (average of 3819 nuclei per sample) including 52,706 (58%) astrocytes and 27,592 (30%) microglia. Smaller numbers of nuclei from neurons, oligodendrocytes, and vascular cells also were found (Extended Data Fig. 2, online resource), but these cell types formed distinct UMAP clusters that were not analysed further. c Heatmap showing cell type-specific marker gene expression in the nuclei clusters. d Heatmap of top differentially expressed genes in each microglial cluster. e Heatmap of top differentially expressed genes in each astrocyte cluster
Fig. 1 Analysis of human brain microglia and astrocytes from low and high AD pathology brains by single-nuclei RNASeq. a FACS gating method for sorting of human brain nuclei to enrich for microglia and astrocyte double-negative population (pink; mean for 24 samples = 17.9%, standard deviation = 6.2%). Dapi + ve nuclei were selected first, followed by separation based on NeuN and Sox10 staining. b UMAP 2D visualisation of clustering of 91,655 single nuclei from the 24 brain samples (average of 3819 nuclei per sample) including 52,706 (58%) astrocytes and 27,592 (30%) microglia. Smaller numbers of nuclei from neurons, oligodendrocytes, and vascular cells also were found (Extended Data Fig. 2, online resource), but these cell types formed distinct UMAP clusters that were not analysed further. c Heatmap showing cell type-specific marker gene expression in the nuclei clusters. d Heatmap of top differentially expressed genes in each microglial cluster. e Heatmap of top differentially expressed genes in each astrocyte clusterCC BY · PubMed Central
Fig. 2 Differential gene expression in astrocytes and microglia with amyloid-beta and pTau pathology. Volcano plot of transcripts differentially expressed in astrocyte nuclei (threshold of ≤ 0.05 adjusted p value, abs logFC ≥ 0.25, omitting the top three most variable genes between samples) with immunohistochemically defined tissue amyloid-beta (a) and pTau (b) density. c Venn diagram illustrating the number of genes positively correlated (top) and negatively correlated (bottom) with amyloid-beta (blue) and pTau pathology (pink) in astrocytes. Volcano plot of transcripts differentially expressed in microglial nuclei (threshold of ≤ 0.05 adjusted p value, abs logFC ≥ 0.25, omitting the top three most variable genes between samples) with immunohistochemically defined tissue amyloid-beta (d) and pTau (e) density. f Venn diagram illustrating the number of genes positively correlated (top) and negatively correlated (bottom) with amyloid-beta (blue) and pTau (pink) pathology in microglia
Fig. 2 Differential gene expression in astrocytes and microglia with amyloid-beta and pTau pathology. Volcano plot of transcripts differentially expressed in astrocyte nuclei (threshold of ≤ 0.05 adjusted p value, abs logFC ≥ 0.25, omitting the top three most variable genes between samples) with immunohistochemically defined tissue amyloid-beta (a) and pTau (b) density. c Venn diagram illustrating the number of genes positively correlated (top) and negatively correlated (bottom) with amyloid-beta (blue) and pTau pathology (pink) in astrocytes. Volcano plot of transcripts differentially expressed in microglial nuclei (threshold of ≤ 0.05 adjusted p value, abs logFC ≥ 0.25, omitting the top three most variable genes between samples) with immunohistochemically defined tissue amyloid-beta (d) and pTau (e) density. f Venn diagram illustrating the number of genes positively correlated (top) and negatively correlated (bottom) with amyloid-beta (blue) and pTau (pink) pathology in microgliaCC BY · PubMed Central
Fig. 3 Functional enrichment of differential gene expression with amyloid-beta (left) and pTau (right) pathology in astrocytes. The plots describe the significant functionally enriched pathways in astrocytes obtained using enrichR (see “Methods”) from Gene Ontology (GO), Reactome, and Wikipathways (WP) databases
Fig. 3 Functional enrichment of differential gene expression with amyloid-beta (left) and pTau (right) pathology in astrocytes. The plots describe the significant functionally enriched pathways in astrocytes obtained using enrichR (see “Methods”) from Gene Ontology (GO), Reactome, and Wikipathways (WP) databasesCC BY · PubMed Central
Fig. 4 Functional enrichment of differential gene expression with amyloid-beta (left) and pTau (right) pathology in microglia. The plots describe the significant functionally enriched pathways in microglia obtained using enrichR (see “Methods”) from Gene Ontology (GO), Reactome, and Wikipathways (WP) databases
Fig. 4 Functional enrichment of differential gene expression with amyloid-beta (left) and pTau (right) pathology in microglia. The plots describe the significant functionally enriched pathways in microglia obtained using enrichR (see “Methods”) from Gene Ontology (GO), Reactome, and Wikipathways (WP) databasesCC BY · PubMed Central
Fig. 5 GPNMB is a hub gene in microglial gene co-expression modules up-regulated with AD pathology. a Graph of microglial gene co-expression module 11 enriched with amyloid-beta and pTau pathology for which GPNMB is a hub gene (triangles = module hub genes). GPNMB is expressed in regulons identified by their transcription factors (in green). b Immunohistochemical staining of GPNMB in post-mortem human brain tissue from representative NDC and AD brains with nuclear counterstain. Staining is present in both microglia and perivascular macrophages (insets). Scale = 100 μm. c Quantification of density of GPNMB-positive cells in cortical tissue by automated image analysis showing an increase in GPNMB-positive cells per μm2 for AD cases compared to NDC (p = 0.0023; Mann–Whitney test, two-tailed; N = 12). Each point represents a single sample and the horizontal bar indicates the median
Fig. 5 GPNMB is a hub gene in microglial gene co-expression modules up-regulated with AD pathology. a Graph of microglial gene co-expression module 11 enriched with amyloid-beta and pTau pathology for which GPNMB is a hub gene (triangles = module hub genes). GPNMB is expressed in regulons identified by their transcription factors (in green). b Immunohistochemical staining of GPNMB in post-mortem human brain tissue from representative NDC and AD brains with nuclear counterstain. Staining is present in both microglia and perivascular macrophages (insets). Scale = 100 μm. c Quantification of density of GPNMB-positive cells in cortical tissue by automated image analysis showing an increase in GPNMB-positive cells per μm2 for AD cases compared to NDC (p = 0.0023; Mann–Whitney test, two-tailed; N = 12). Each point represents a single sample and the horizontal bar indicates the medianCC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 81 references

Cited by

Sorted by citations

See all 219

Metadata

Authors
Smith, A. M., Davey, K., Tsartsalis, S., Khozoie, C., Fancy, N., Tang, S. S., Liaptsi, E., Weinert, M., McGarry, A., Muirhead, R. C. J., Gentleman, S., Owen, D. R., & Matthews, P. M.
Affiliations
  • Hammersmith Hospital (GB)
  • University of Geneva (CH)
Corresponding author
Matthews, Paul M.
Venue
Acta Neuropathologica
Published
2021-11-12
Volume
143
Issue
1
Pages
75-91
ISSN
  • 0001-6322 (ISSN-L)
  • 1432-0533
OpenAlex
W3214651914
Cited by
209
References
81
Citations by year
2026: 43 · 2025: 41 · 2024: 50 · 2023: 49 · 2022: 24 · 2021: 1
FWCI
21.05
Type
journal article
Language
en
Open access
Locations
  • Acta Neuropathologica (publishedVersion, cc-by)
  • bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Archive ouverte UNIGE (University of Geneva) (publishedVersion, other-oa)
  • Archive ouverte UNIGE (University of Geneva) (submittedVersion, cc-by)
Funders
  • National Science Foundation
  • Alzheimer's Society
  • National Institute for Health and Care Research (NIHR202376, NF-SI-0514-10022)
  • Parkinson's UK
  • Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (191446)
  • UK Dementia Research Institute
  • Medical Research Council (MR/K501013/1, MR/N008219/1, MR/M024903/1, MR/T031891/1, MR/N026934/1, MC_PC_17114)
  • NIHR Imperial Biomedical Research Centre
Topics
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Keywords
Alzheimer's disease, astrocytes, microglia, amyloid-beta, phosphorylated tau, single-nucleus RNA sequencing, postmortem brain, apolipoprotein E, clusterin, MEF2C, MS4A6A, proteostasis, inflammation, phagocytosis, metal homeostasis, perivascular macrophages, GPNMB, gene co-expression, disease biomarkers
MeSH terms
Aged, Aged, 80 and over, Alzheimer Disease, Astrocytes, Brain, Female, Humans, Male, Microglia, Transcriptome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review